 INTERVENTIONS The control group will receive standard treatment and monitoring for heart failure from the ambulatory staff where the study will be performed, including pharmacotherapy and health education, as recommended by the health team. The intervention group will receive the standard treatment and ongoing follow-up as well as monitoring by telenursing for a period of 6 months 24 weeks. 